Fig. 3. Antifungal drug use for outpatients stratified by the total number of days’ supply per year per outpatient. A, aspergillosis; IPA, invasive pulmonary aspergillosis; PA, pulmonary aspergillosis; Vori-C, voriconazole; Itra-C, itraconazole; Flu-C, fluconazole

Korean J Clin Pharm 2023;33:113-21 https://doi.org/10.24304/kjcp.2023.33.2.113

© 2023 Korean J Clin Pharm